Mateusz Krakowiak

Dr. Mateusz Krakowiak

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2023 in European Journal of Translational and Clinical Medicine
Verified
Journal Article
Open access
PDF file
NDNadia Dzierżanowska
Nadia Dzierżanowska
MKMateusz Krakowiak
Mateusz Krakowiak
Paweł SokalPaweł Sokal
Paweł Sokal
BMBarbara Myszkowska
Barbara Myszkowska
Background: For about 20 years we have been observing the development of three-dimensional (3D) printing. The aim of this study was to systematize the current knowledge on the use of 3D printing technology in neurosurgery and to attempt an outline the future paths of its development. Material and methods: The analysis was based on English-language literature from 2017-2021 indexed in the Mendeley and Scopus databases. Results: The application of 3D printing in neurosurgery concerns: 1) teaching students, 2) training of residents neurosurgeons, 3) individualized surgery planning, 4) dedicated cranial and spinal implants, 5) the future of 3D printing in neurosurgical implantology. There were 5 main neurosurgery subtopics in which 3D printing was used: “vascular neurosurgery” (31%), “skull, cranial neurosurgery” (22.4%), “neuro-oncology” (19.3%), “spine” (14.3%) and “others” (13%). The number of published articles has been steadily increasing by 11-33% annually. Conclusion: 3D printing has an enormous potential for clinical use and in the we will continue to observe its dynamic development. In neurosurgery 3D prints are currently most commonly used for didactic purposes as detailed anatomical models, for training residents and young surgeons and by specialists for the simulation of complex or innovative surgeries. The future of the use of additive 3D printing in neurosurgery lies in the biological 3D printing, the creation of artificial organs and the development of biological implants in tissue engineering.

Verified
Journal Article
Open access
PDF file
BKBartłomiej Kulesza
Bartłomiej Kulesza
MKMateusz Krakowiak
Mateusz Krakowiak
ABAgnieszka Brzozowska
Agnieszka Brzozowska
CGCezary Grochowski
Cezary Grochowski
RMRyszard Maciejewski
Ryszard Maciejewski
Background: Prognostic assessment in patients undergoing surgical treatment for acute extra-axial hematomas remains challenging. Most available prognostic models have been developed in heterogeneous populations of patients with traumatic brain injury, while relatively few studies have focused exclusively on surgically treated patients with acute subdural hematoma (ASDH) and epidural hematoma (EDH). Although mortality has been widely investigated, less attention has been paid to early functional recovery after surgery. This study aimed to identify clinical, physiological, laboratory, and radiological factors associated with early functional outcome three months after surgery in this patient population. Methods: We retrospectively analyzed 181 consecutive patients who underwent surgical treatment for acute extra-axial hematomas at two neurosurgical centers. Demographic, physiological, laboratory, and radiological variables recorded on admission were evaluated. Functional outcome was assessed three months after surgery using the Glasgow Outcome Scale (GOS). Favorable outcome was defined as GOS 4–5 and unfavorable outcome as GOS 1–3. Independent prognostic factors were identified using multivariable logistic regression analysis. Results: An unfavorable outcome was observed in 105 patients (58.0%). Multivariable analysis identified higher admission GCS score as the strongest independent predictor of a favorable functional 3-month outcome (OR = 1.45, 95% CI: 1.27–1.65; p < 0.001). The presence of an epidural hematoma (OR = 5.77, 95% CI: 1.36–24.47; p = 0.018) was also independently associated with a favorable functional outcome. Conversely, traumatic subarachnoid hemorrhage (OR = 0.19, 95% CI: 0.07–0.52; p = 0.001), hyperglycemia (OR = 0.20, 95% CI: 0.05–0.78; p = 0.020), and low hemoglobin levels (reference: normal hemoglobin; OR = 0.18, 95% CI: 0.06–0.54; p = 0.002) were associated with a lower likelihood of favorable functional outcome. Conclusions: Admission neurological status, represented by the GCS score, was the strongest predictor of 3-month functional outcome in patients undergoing surgical treatment for acute extra-axial hematomas. Hematoma type, hemoglobin level, traumatic subarachnoid hemorrhage, and hyperglycemia were also independently associated with outcome. These findings may improve early prognostic assessment; however, because of the retrospective study design and the lack of external validation, they should be interpreted with caution.

1 September 2025 in Clinical Medicine And Health Research Journal
Verified
Journal Article
Open access
PDF file
BMBarbara Myszkowska
Barbara Myszkowska
ZPZawada-Wiśniewska P.
Zawada-Wiśniewska P.
HIHandzlik I.
Handzlik I.
MKMateusz Krakowiak
Mateusz Krakowiak
The medical community has long linked microaneurysm rupture risk to size. Larger bulges were thought to be more dangerous. But recent clinical findings have turned this conventional wisdom on its head. Even the smallest aneurysms can seriously threaten brain health. Studies now show that tiny aneurysms (≤3 mm) cause much of the subarachnoid hemorrhage cases. This discovery challenges risk assessment protocols that doctors have used for decades. These small vascular abnormalities can show no warning signs before a catastrophic rupture. Scientists understand a lot about macroaneurysm rupture. The mechanisms behind small aneurysm failures remain nowhere near as clear. The anterior communicating artery (AComA) seems to increase rupture risk whatever the size. Research continues on whether fusiform aneurysms follow this same pattern. Medical teams still debate the best way to manage these dangerous vascular anomalies. This piece dives into fresh evidence that challenges size-based risk models for brain aneurysms. We'll learn about the surprising relationship between aneurysm size and rupture risk. The text explores location-specific vulnerability patterns and reviews current treatment approaches for these overlooked vascular threats. Doctors need this knowledge to make intervention decisions. Patients need it to weigh treatment options against the risk of catastrophic bleeding.

22 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BKBartłomiej Kulesza
Bartłomiej Kulesza
MKMateusz Krakowiak
Mateusz Krakowiak
DLDorota Luchowska-Kocot
Dorota Luchowska-Kocot
Jacek KurzepaJacek Kurzepa
Jacek Kurzepa
CGCezary Grochowski
Cezary Grochowski
RMRyszard Maciejewski
Ryszard Maciejewski
Background: Acute subdural hematoma (ASDH) and chronic subdural hematoma (ChSDH) differ substantially in their pathophysiology, clinical course, and outcomes. Matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, have been implicated in blood–brain barrier disruption, extracellular matrix remodeling, and inflammatory processes involved in both traumatic brain injury and ChSDH. However, direct comparisons of perioperative MMP profiles between ASDH and ChSDH and their relationships with clinical characteristics remain limited. The aim of this study was to compare perioperative MMP-2 and MMP-9 concentrations in patients with ASDH and ChSDH and explore their associations with selected clinically relevant parameters. Methods: Thirty patients undergoing surgical treatment for subdural hematoma were prospectively enrolled, including 10 patients with ASDH and 20 with ChSDH. Serum samples were collected before surgery and on postoperative day 3, and hematoma content was obtained intraoperatively. MMP-2 and MMP-9 concentrations were measured using enzyme-linked immunosorbent assay. Results: Patients with ASDH had significantly higher MMP-9 concentrations in hematoma content (p = 0.002) and postoperative serum (p = 0.029) than patients with ChSDH, whereas MMP-2 concentrations did not differ significantly between the groups. In the ChSDH group, both MMP-2 and MMP-9 concentrations were significantly lower in hematoma content than in preoperative and postoperative serum, while no significant perioperative changes were observed in patients with ASDH. Higher MMP-2 concentrations in hematoma content were associated with lower leukocyte counts and smaller midline shift, whereas higher hematoma MMP-9 concentrations were associated with lower APTT and CRP concentrations after FDR correction. These findings suggest distinct perioperative MMP-2 and MMP-9 profiles in acute and chronic subdural hematomas. Conclusions: This study provides a direct comparison of perioperative MMP-2 and MMP-9 profiles in serum and hematoma content between patients with ASDH and ChSDH while also exploring their associations with selected clinically relevant parameters.

2 September 2015 in Folia Morphologica
Verified
Journal Article
Closed access
MKMateusz Krakowiak
Mateusz Krakowiak
PSP. Słoniewski
P. Słoniewski
JDJ. Dzierżanowski
J. Dzierżanowski
Tomasz SzmudaTomasz Szmuda
Tomasz Szmuda
Tractography is a tool available in a growing number of centres, to enable planning of neurosurgical interventions. This method has some drawbacks and due to its increasing availability is causing a growing controversy over the possibility of an anatomical mapping of the nerve fibres. This article aims at summarising the application of the diffusion magnetic resonance in contemporary neurosurgery method, showing the usefulness and merits of its performance before surgical procedures, limitation of its application and recommendations for its improvement and more effective use for diagnostic purposes.

20 May 2026 in European Journal of Translational and Clinical Medicine
Verified
Journal Article
Open access
PDF file
MKMateusz Krakowiak
Mateusz Krakowiak
DPDamian Palus
Damian Palus
VMVishnu Prakash Mundayadan
Vishnu Prakash Mundayadan
BMBarbara Myszkowska
Barbara Myszkowska
CGCezary Grochowski
Cezary Grochowski
PSPaweł Sokal
Paweł Sokal
Endoscopic spine surgery: methodology and outcomes based on patient feedback. Background: Endoscopic lumbar decompression (ELD) is emerging as a minimally invasive alternative to traditional microdiscectomy, potentially offer...